About Dow

Dow Biomedica is a market developer & distributor of in-vitro diagnostics products.
Through partnership with global leaders, we are introducing cutting-edge technology products to our customers.

Cleveland Diagnostics Signs Distribution Agreement with Dow BioMedica to Bring Prostate Cancer Test, IsoPSA, to Korea
by 운영자 | Date 2024-04-17 14:23:28 전체목록

CLEVELAND, April 13, 2024 Cleveland Diagnostics, a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers has signed a distribution agreement with Dow BioMedica, a trusted distributor of life science solutions for biotechnology, clinical research organizations, and universities. Under this agreement, Dow BioMedica will exclusively distribute Cleveland Diagnostics’ IsoPSA prostate cancer test in Korea.

원문 링크 https://finance.yahoo.com/news/cleveland-diagnostics-signs-distribution-agreement-040000121.html?guccounter=1